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The continuous influx of patients in need of speech-language pathology services makes it mandatory that 
speech-language pathologists begin to give careful consideration to the selection process used in identifying 
those patients with communication disorders who will benefit from a treatment program. Equally important is 
the establishment of criteria for terminating patients from treatment. 
 
Within an adult hospital setting, one of the most prominent communication disorders observed among patients 
is aphasia. Aphasia is a language processing disorder resulting from damage to the linguisitic areas of the brain, 
usually located in the left hemisphere. Common causes of the brain damage include cerebrovascular accidents, 
brain tumors, head trauma, cerebral atrophy, encephalitis, and brain absesses. 
 
Because of the predominance of aphasia among adult patients, this report focuses on identifying those 
candidacy determinants that have proved useful in selecting patients who would benefit from aphasia treatment 
programs. In addition, criteria for terminating aphasic patients from treatment are considered. 
 
After conducting an extensive review of the literature and surveying prominent aphasiologists by telephone, the 
following guidelines for patient selection and treatment termination were establishd: 
 
I. PROPOSED GUIDELINES FOR SELECTION OF PATIENTS FOR APHASIA THERAPY 
In selecting aphasic patients for treatment, the following factors may be considered along with the ordering of 
priorities shown under each factor: 
 
A. AGE 
Priority 1 Less than 55 years 
Priority 2 55-75 years 
Priority 3 Greater than 75 years 
B. RECENCY OF ONSET 
Priority 1 0-6 months post onset stroke 
Priority 2 7-12 months post onset stroke  
 
Priority 3 Greater than 1 year post onset stroke co  
 
C. ETIOLOGY 
Priority 1 Embolic, traumatic 
Priority 2 Infectious 
Priority 3 Hemorrhagic 
D. TYPE OF APHASIA 
Priority 1 Patients demonstrating anomia, conduction, transcortical motor or transcortical sensory aphasia 
Priority 2 Patients demonstrating Broca's or Wernicke's aphasia 
Priority 3 Patients demonstrating global aphasia or senile dementia 
E. SENSORY/ PERCEPTUAL BEHAVIOR 
Priority 1 Patients demonstrating functional hearing and visual acuity and perception who are alert 
(stimulated and aroused by the environment) and attentive 
Priority 2 Patients demonstrating visual, auditory and/or attentional deficits (i.e., visual field cuts, dis-
tractibility, stupor, lethargy) 
 
F .  PSYCHOLOGICAL BEHAVIVR 
Priority 1 Patients demonstrating an adequate motivational level (i.e., engages in therapy activities, attends 
regularly, displays limited irritability) 
Priority 2 Patients demonstrating poor motivation (i.e., refuses to participate or cooperate during therapy 
activities, fatigues easily, emotionally labile, complains frequently, denies that a problem 
exists) 
Priority 3 Patients with severe psychiatric involvement 
G .  PREVIOUS THERAPY 
Priority 1 Patients with no previous therapy 
Priority 2 Patients who have been referred to the service from other agencies with recommendations to 
continue a therapy program 
Priority 3 Patients who have achieved maximum benefits from a previous aphasia therapy program within a 
1-year period 
 
II. PROPOSED CRITERIA FOR TERMINATING APHASIC PATIENTS FROM TREATMENT 
Aphasic patients should be discharged from therapy when: 
A. Treatment goals are achieved as indicated by measurable gains on test-retest evaluations and the patient is 
meeting levels of criteria established on individual therapy tasks 
B. No measurable progress is demonstrated during a 1-2 month trial period of therapy as indicated by test-
retest evaluations and criteria-referenced therapy tasks 
C. The patient elects to teminate treatment 
D. Medical complications preclude continuation of the therapy program 
E. The patient, exhibits excessive and continuous absenteeism (i.e., patient does not attend 75% of scheduled 
appointments) 
 
References which contributed to the establishment of these guidelines are available upon request to the authors. 
